Research for Impact
International Ivermectin Covid Conference 24 and 25 the April 2021
The conference has been recorded. Please go to for the recordings or click the button. Please see below Dr Lawrie's powerful closing speech.
Dr Lawrie's messages
Links to subtitled messages
Message to the PUBLIC
Message to DOCTORS
For your MP
For your GP
Please be advised that the content in the FAQ does not constitute medical advice. It is up to you and your doctor to agree on a treatment.
Summary of evidence
Please edit and use these to send to your Member of Parliament and your GP. Click and they will download automatically.
British Ivermectin Recommendation Development Panel – Response to EMA Statement on Ivermectin for Covid-19
Read the rebuttal to the European Medicines Agency's pronouncement on ivermectin.
BIRD 3 Meeting Sat 20 March
Public Survey Results
Here are the rusults of the public survey of the BIRD EtD framework prentation on the 18-2-21
Dr David Chesler's letter to the NIH
Download/View Cochrane Protocol
22 Febuary 2021
British Ivermectin Recommendation Development (BIRD) Webinar was held on the 20th February 2021 at 14h00 GMT.
What was the aim of the meeting?
To review the evidence on Ivermectin to potentially prevent and treat covid-19, with a view to reaching a consensus and making recommendation/s on its further investigation or use.
13 January 2021
British Ivermectin Recommendation Development (BIRD) Meeting held Wednesday 13th January 2021
The BIRD meeting was convened by Dr. Tess Lawrie in order to present the findings from her rapid systematic review and meta-analysis of studies on the use of ivermectin to prevent and treat COVID-19.
Dr. Lawrie presented evidence in the form of a DECIDE evidence-to-decision framework, a format used by the World Health Organization for the development of guidelines and recommendations in medical practice.
Twenty experts from around the world and the UK attended the meeting, including 13 clinicians, and seven representatives from the public.
British Ivermectin Recommendation Development (BIRD) Group draft Evidence to Decision (EtD) framework.
03 January 2021
Covid-19 information for health professionals and policymakers:
Ivermectin reduces the risk of death from COVID-19 - A rapid review and meta-analysis in support of the recommendation of the Front Line COVID-19 Critical Care Alliance
The Evidence-Based Medicine Consultancy Ltd is an independent medical research company that makes meaningful contributions to the quality of healthcare globally through rigorous research and innovative healthcare research methodology.
We conduct original research and provide research support to national and international health organisations, research teams, healthcare professionals and service users with the best possible evidence to inform healthcare decision-making.
For healthcare guideline development, we conduct evidence syntheses to inform stakeholder decision-making. We are also actively involved in the innovation and evolution of guideline methodology to improve the applicability and implementation of healthcare recommendations and guidelines.
Guideline development and derivative products
Cochrane and other systematic reviews
Clinical trial protocols
User testing studies
Teaching videos and promotional material
Clinical practice manuals
Manuscript writing services
Expertise in evidence synthesis and scientific writing.
Expertise in guideline development methodology.
Extensive network of expert collaborators globally.
Experience in low, middle and high-income countries and different settings.
High level of scientific integrity.
Committed to meeting deadlines.
Excellent reputation for creative solutions.
We have many happy clients.
Why use us
Tess (MBBCh, DFSRH, PhD), as director of E-BMC Ltd, is committed to improving the quality of healthcare through rigorous research. Her range of research expertise, based on research experience in both developing and developed countries, uniquely positions her to evaluate and design research for a variety of healthcare settings. Tess is a frequent member of technical teams responsible for developing international guidelines. Her peer-reviewed publications have received in excess of 2000 citations and her ResearchGate score is among the top 5% of ResearchGate members.
Tess (MBBCh, DFSRH, PhD), as director of E-BMC Ltd, is committed to improving the quality of healthcare through rigorous research. Her range of research expertise, based on research experience in both developing and developed countries, uniquely positions her to evaluate and design research for a variety of healthcare settings. Tess is a frequent member of technical teams responsible for developing international guidelines. Her peer-reviewed publications have received in excess of 3000 citations and her ResearchGate score is among the top 5% of ResearchGate members.
Ewelina (MSc, PhD) is an experienced systematic reviewer whose expertise includes the methodology of meta-analyses using individual participant and test accuracy data. She also has considerable experience in managing evidence synthesis projects and their teams.
Education and work experience:
Therese, PhD BSc (econ), is a systematic reviewer with considerable experience in Cochrane and GRADE methodology. Previously she worked with the Cochrane Pregnancy and Childbirth Group in Liverpool where she was frequently involved in international healthcare guideline development.
Publications and other supported projects
Please fill in the form or email us at
Please note that neither this site nor E-BMC Ltd retains any information entered in this form.
Bath, United Kingdom